JP2022513562A5 - - Google Patents

Info

Publication number
JP2022513562A5
JP2022513562A5 JP2021516582A JP2021516582A JP2022513562A5 JP 2022513562 A5 JP2022513562 A5 JP 2022513562A5 JP 2021516582 A JP2021516582 A JP 2021516582A JP 2021516582 A JP2021516582 A JP 2021516582A JP 2022513562 A5 JP2022513562 A5 JP 2022513562A5
Authority
JP
Japan
Prior art keywords
kda
protein
serotypes
polysaccharide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021516582A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513562A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/058036 external-priority patent/WO2020058963A1/en
Publication of JP2022513562A publication Critical patent/JP2022513562A/ja
Publication of JP2022513562A5 publication Critical patent/JP2022513562A5/ja
Priority to JP2024130732A priority Critical patent/JP2024160305A/ja
Withdrawn legal-status Critical Current

Links

JP2021516582A 2018-09-23 2019-09-23 肺炎連鎖球菌の精製された莢膜多糖 Withdrawn JP2022513562A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024130732A JP2024160305A (ja) 2018-09-23 2024-08-07 肺炎連鎖球菌の精製された莢膜多糖

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN201841031653 2018-09-23
IN201841031654 2018-09-23
IN201841031654 2018-09-23
IN201841031653 2018-09-23
PCT/IB2019/058036 WO2020058963A1 (en) 2018-09-23 2019-09-23 Purified capsular polysaccharides of streptococcus pneumoniae

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024130732A Division JP2024160305A (ja) 2018-09-23 2024-08-07 肺炎連鎖球菌の精製された莢膜多糖

Publications (2)

Publication Number Publication Date
JP2022513562A JP2022513562A (ja) 2022-02-09
JP2022513562A5 true JP2022513562A5 (cg-RX-API-DMAC7.html) 2022-10-03

Family

ID=69886702

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021516582A Withdrawn JP2022513562A (ja) 2018-09-23 2019-09-23 肺炎連鎖球菌の精製された莢膜多糖
JP2024130732A Pending JP2024160305A (ja) 2018-09-23 2024-08-07 肺炎連鎖球菌の精製された莢膜多糖

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024130732A Pending JP2024160305A (ja) 2018-09-23 2024-08-07 肺炎連鎖球菌の精製された莢膜多糖

Country Status (12)

Country Link
US (2) US12048739B2 (cg-RX-API-DMAC7.html)
EP (1) EP3852795A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022513562A (cg-RX-API-DMAC7.html)
KR (1) KR102879391B1 (cg-RX-API-DMAC7.html)
CN (1) CN113164581A (cg-RX-API-DMAC7.html)
AU (1) AU2019341723C1 (cg-RX-API-DMAC7.html)
BR (1) BR112021005425A2 (cg-RX-API-DMAC7.html)
MX (1) MX2021003358A (cg-RX-API-DMAC7.html)
MY (1) MY206212A (cg-RX-API-DMAC7.html)
PH (1) PH12021550539A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020058963A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202101663B (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
EP3720483B1 (en) 2017-12-06 2025-11-19 Merck Sharp & Dohme LLC Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP3897705A2 (en) 2018-12-19 2021-10-27 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
CA3142692A1 (en) * 2019-06-05 2020-12-10 Merck Sharp & Dohme Corp. An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same
AU2021262999A1 (en) 2020-05-01 2023-01-19 Sinocelltech Ltd. Method for improving immunogenicity of protein/peptide antigen
US20230383324A1 (en) * 2020-10-22 2023-11-30 Pfizer Inc. Methods for purifying bacterial polysaccharides
CA3200602A1 (en) * 2020-11-04 2022-05-12 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US20240123047A1 (en) * 2021-02-04 2024-04-18 Merck Sharp & Dohme Llc Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccines
JP2025531339A (ja) * 2022-09-19 2025-09-19 バイオロジカル イー リミテッド 莢膜ポリサッカライドの精製法
CN117512031B (zh) * 2023-10-16 2024-06-25 江苏金迪克生物技术股份有限公司 一种肺炎球菌荚膜多糖的纯化方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027888B1 (en) 1979-09-21 1986-04-16 Hitachi, Ltd. Semiconductor switch
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
EP0625910B1 (en) 1992-02-11 2003-07-23 Henry M. Jackson Foundation For The Advancement Of Military Medicine Dual carrier immunogenic construct
DK0616034T3 (da) 1993-03-05 2005-02-21 Wyeth Corp Plasmid til fremstilling af CRM-protein og diphtheria toxin
EP0720485B1 (en) 1993-09-22 2003-11-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
DE69628418T2 (de) 1995-03-22 2004-04-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
US6299881B1 (en) 1997-03-24 2001-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
RU2672053C2 (ru) * 2012-12-20 2018-11-09 Пфайзер Инк. Способ гликоконъюгации
FI3583947T3 (fi) * 2014-01-21 2023-10-12 Pfizer Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit
IL312327B2 (en) 2014-01-21 2026-02-01 Pfizer Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
MX388191B (es) 2014-11-20 2025-03-19 Biological E Ltd Polinucleótido optimizado por codones para la expresión de alto nivel de crm197.
GB201518684D0 (en) * 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
HUE049756T2 (hu) 2015-11-09 2020-10-28 Biological E Ltd Ipari méretekben is alkalmazható eljárás biológiailag aktív, rekombináns hordozófehérjék kinyerésére
US11058757B2 (en) * 2016-03-31 2021-07-13 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
CN109789198B (zh) * 2016-09-30 2024-08-16 生物E有限公司 包含多糖-蛋白缀合物的多价肺炎球菌疫苗组合物
IL267709B2 (en) * 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
JP7680185B2 (ja) * 2017-02-24 2025-05-20 メルク・シャープ・アンド・ドーム・エルエルシー 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強
BR112019022093A2 (pt) 2017-04-22 2020-05-05 Biological E Limited método aprimorado para a produção em alto nível de crm
CN111065387B (zh) 2017-09-07 2023-08-25 默沙东有限责任公司 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途
HUE068482T2 (hu) 2017-09-07 2025-01-28 Merck Sharp & Dohme Llc Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban
CA3074706A1 (en) 2017-09-07 2019-03-14 Merck Sharp & Dohme Corp. Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Similar Documents

Publication Publication Date Title
JP2021512870A5 (cg-RX-API-DMAC7.html)
IL276229B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
TW202617178A (zh) 多價肺炎球菌多醣-蛋白質共軛物組成物及使用其之方法
JP2021505589A5 (cg-RX-API-DMAC7.html)
JP2019526621A5 (cg-RX-API-DMAC7.html)
IL276230B2 (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
JP2022542316A5 (cg-RX-API-DMAC7.html)
SA519401027B1 (ar) تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين
FI3720483T3 (fi) Streptococcus pneumoniaen polysakkaridi-proteiinikonjugaatteja käsittäviä koostumuksia ja niiden käyttömenetelmiä
JP2020533438A5 (cg-RX-API-DMAC7.html)
JP2020533437A5 (cg-RX-API-DMAC7.html)
HRP20110685T1 (hr) Cjepivo od konjugata pneumokoknog polisaharida
JP2019526620A5 (cg-RX-API-DMAC7.html)
PE20161095A1 (es) Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos
HRP20221438T1 (hr) Postupak glikokonjugiranja
PE20211888A1 (es) Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso
JP2020533442A5 (cg-RX-API-DMAC7.html)
RU2016136630A (ru) Способы гликоконъюгирования и композиции
EA200901578A1 (ru) Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
JP2018516962A5 (cg-RX-API-DMAC7.html)
SA519401028B1 (ar) تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين
BR112015016817B1 (pt) métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica
CN108524926B (zh) 一种多价肺炎球菌结合疫苗的制剂组合及其应用
WO2024241172A3 (en) Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
NZ775208A (en) Purified capsular polysaccharides of streptococcus pneumoniae